SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 481 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,269,555 | +20.2% | 27,023 | -1.5% | 0.36% | +9.8% |
| Q1 2024 | $3,551,023 | +34.4% | 27,430 | +0.1% | 0.33% | +33.5% |
| Q4 2023 | $2,641,849 | -21.4% | 27,398 | -1.2% | 0.24% | -30.6% |
| Q3 2023 | $3,362,444 | +8.1% | 27,740 | +2.1% | 0.35% | +11.4% |
| Q2 2023 | $3,111,109 | -18.3% | 27,168 | -1.6% | 0.32% | +49.5% |
| Q1 2023 | $3,805,838 | +3.4% | 27,611 | -2.8% | 0.21% | +29.3% |
| Q4 2022 | $3,679,775 | -8.9% | 28,398 | -22.3% | 0.16% | -31.4% |
| Q3 2022 | $4,041,000 | +47.0% | 36,554 | +0.7% | 0.24% | -2.0% |
| Q2 2022 | $2,749,000 | -3.4% | 36,315 | -0.3% | 0.24% | +52.5% |
| Q1 2022 | $2,846,000 | -8.4% | 36,427 | +5.6% | 0.16% | -39.2% |
| Q4 2021 | $3,106,000 | +11.8% | 34,491 | -7.5% | 0.26% | +18.5% |
| Q1 2021 | $2,778,000 | -47.3% | 37,274 | +20.5% | 0.22% | -54.4% |
| Q4 2020 | $5,273,000 | – | 30,930 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,369,909 | $84,126,000 | 14.76% |
| Perceptive Advisors | 3,395,236 | $208,506,000 | 13.46% |
| Ghost Tree Capital, LLC | 400,000 | $24,564,000 | 3.98% |
| Granite Point Capital Management, L.P. | 160,000 | $9,826,000 | 3.84% |
| Sio Capital Management, LLC | 86,500 | $5,312,000 | 3.66% |
| Ghost Tree Capital, LLC | 350,000 | $21,494,000 | 3.49% |
| Redmile Group, LLC | 640,400 | $39,327,000 | 3.13% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 78,408 | $4,815,000 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 263,047 | $16,154,000 | 2.63% |
| FT Options LLC | 49,025 | $3,011,000 | 2.39% |